Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Breast Neoplasms 6Triple Negative Breast Neoplasms 4Pancreatic Neoplasms 3Ovarian Neoplasms 2Neoplasm Metastasis 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Myeloid, Acute 2Glioblastoma 2Thrombocythemia, Essential 1Testicular Neoplasms 1Small Cell Lung Carcinoma 1Renal Insufficiency 1Rectal Neoplasms 1Primary Myelofibrosis 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycythemia Vera 1Pathologic Complete Response 1Neoplasms, Unknown Primary 1Neoplasms 1Myelodysplastic-Myeloproliferative Diseases 1Melanoma 1Lung Neoplasms 1Liver Failure 1Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1Hemangiosarcoma 1Head and Neck Neoplasms 1Gliosarcoma 1Glioma 1

Interventions

Interviews as Topic 3Educational Status 3Specimen Handling 2Palliative Care 2Methods 2Early Intervention, Educational 2veliparib 1spartalizumab 1siltuximab 1pamiparib 1dinaciclib 1cabozantinib 1Pharmacogenomic Variants 1Patient Comfort 1Paclitaxel 1Nutrition Assessment 1Mindfulness-Based Stress Reduction 1Mindfulness 1Magnetic Resonance Spectroscopy 1Health Promotion 1Diet Therapy 1Biopsy 1Behavior Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Advanced Malignant Solid Neoplasm × veliparib × 1 year × Clear all
NCT01434316 2026-04-13

Veliparib and Dinaciclib in Treating Patients With Advanced Solid Tumors

National Cancer Institute (NCI)

Phase 1 Active not recruiting
121 enrolled
Other solid neoplasm

Advanced Malignant Solid Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡